Acanthosis nigricans
☆ AI Dermatology — Free Service
Tamin'ny valin'ny Stiftung Warentest 2022 avy any Alemaina, ny fahafaham-pon'ny mpanjifa amin'ny ModelDerm dia ambany kely noho ny fifampidinihana telemedicine karama.
Tamin'ny valin'ny Stiftung Warentest 2022 avy any Alemaina, ny fahafaham-pon'ny mpanjifa amin'ny ModelDerm dia ambany kely noho ny fifampidinihana telemedicine karama.
Olona matavy be io.
relevance score : -100.0%
ReferencesNy Acanthosis nigricans dia fisehoana amin'ny hoditry aretina iray. Matetika izy io miseho eo amin'ny fonon‑koditra, toy ny tenda, ny valahany ary ny tenda, toy ny tasy mainty volofotsy misy sisiny tsy mazava. Ity toe‑javatra ity dia matetika mifandray amin'ny diabeta sy ny fanoherana ny insuline, saingy amin'ny tranga tsy fahita firy dia mety manondro homamiadana ao anatin'ny vatana izany. Mety hiseho ihany koa izy io noho ny olana momba ny hormonina na avy amin'ny fihinanana fanafody manokana toy ny steroid sy pilina fanabeazana aizana.
Acanthosis nigricans is a cutaneous manifestation of an underlying condition. It usually develops in skin folds, such as the back of the neck, axilla, and groin, where it presents as velvety hyper-pigmented patches with poorly defined borders. Acanthosis nigricans is most commonly associated with diabetes and insulin resistance, but rarely it can be a sign of internal malignancy. It can also occur with hormone disorders or with the use of certain medications like systemic glucocorticoids and oral contraceptives.
Acanthosis nigricans is a cutaneous manifestation of an underlying condition. It usually develops in skin folds, such as the back of the neck, axilla, and groin, where it presents as velvety hyper-pigmented patches with poorly defined borders. Acanthosis nigricans is most commonly associated with diabetes and insulin resistance, but rarely it can be a sign of internal malignancy. It can also occur with hormone disorders or with the use of certain medications like systemic glucocorticoids and oral contraceptives.
Acanthosis nigricans (AN) dia aretina hoditra mahazatra mifandray amin'ny olana ara-pahasalamana isan-karazany toy ny fanoherana ny insuline, ny diabeta, ny matavy loatra, ny homamiadana sasany, ny olana amin'ny hormonina, ary ny fihetsiky ny fanafody. Ny fitsaboana AN dia mifantoka amin'ny famahana ireo olana ara-pahasalamana. Voalohany, ny dokotera dia manara-maso ny soritr'aretina amin'ny insuline resistance syndrome, izay ahitana matavy loatra, kolesterola avo, tosidra ambony ary diabeta karazany 2. Matetika, ny dokotera dia manome topical retinoids ho safidy voalohany amin'ny fitsaboana, izay afaka manampy amin'ny fanamafisana ny hoditra. Na izany aza, mety tsy hanala tanteraka ny fanamaizina ny hoditra izy ireo. Ny safidy fitsaboana hafa (salicylic acid, podophyllin, urea, calcipotriol) koa dia mitaky fampiharana matetika.
Acanthosis nigricans (AN) is a common dermatologic manifestation of systemic disease that is associated with insulin resistance, diabetes mellitus, obesity, internal malignancy, endocrine disorders, and drug reactions. Treatment of AN primarily focuses on resolution of the underlying disease processes causing the velvety, hyperpigmented, hyperkeratotic plaques found on the skin. Initial considerations for the AN workup include evaluating patients for insulin resistance syndrome characterized by obesity, dyslipidemia, hypertension, and diabetes mellitus type II. For cosmetic treatment, topical retinoids are considered the first-line therapy for insulin-resistant AN by modifying keratinization rate. However, topical tretinoin requires application for long durations and improves hyperkeratosis, but not hyperpigmentation. Topical salicylic acid, podophyllin, urea, and calcipotriol also require frequent application, while TCA peels may provide a faster and less time-intense burden.
Acanthosis nigricans (AN) is a common dermatologic manifestation of systemic disease that is associated with insulin resistance, diabetes mellitus, obesity, internal malignancy, endocrine disorders, and drug reactions. Treatment of AN primarily focuses on resolution of the underlying disease processes causing the velvety, hyperpigmented, hyperkeratotic plaques found on the skin. Initial considerations for the AN workup include evaluating patients for insulin resistance syndrome characterized by obesity, dyslipidemia, hypertension, and diabetes mellitus type II. For cosmetic treatment, topical retinoids are considered the first-line therapy for insulin-resistant AN by modifying keratinization rate. However, topical tretinoin requires application for long durations and improves hyperkeratosis, but not hyperpigmentation. Topical salicylic acid, podophyllin, urea, and calcipotriol also require frequent application, while TCA peels may provide a faster and less time-intense burden.
○ Ny antony
Matetika izy io dia mitranga amin'ny olona latsaky ny 40 taona, mety ho lova ara-pananahana ary mifandray amin'ny lanja be loatra na endocrinopathies, toy ny hypothyroidism, acromegaly, polycystic ovaire, diabeta mahatohitra insuline, na aretin'i Cushing.
○ Fitsaboana - Fanafody OTC
#40% urea cream